Estrogen receptor-alpha mediates Toll-like receptor-2 agonist-induced monocyte chemoattractant protein-1 production in mesangial cells

Results in Immunology

Volumn 2, Issue , 2012, Pages 196-203

  Dasgupta, Subhajit ^a   Eudaly, Jackie ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Estrogen; Estrogen receptor ; Lupus nephritis; MCP1; Mesangial cell; TLR2

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; SERINE; TOLL LIKE RECEPTOR 2 AGONIST; TOLL LIKE RECEPTOR AGONIST; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; MESANGIUM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION;

EID: 84870152446     PISSN: None     EISSN: 22112839     Source Type: Journal    
DOI: 10.1016/j.rinim.2012.10.002     Document Type: Article

References (50)

1. Scindia Y.M., Deshmukh U.S., Bagavant H. Mesangial pathology in glomerular disease: targets for therapeutic intervention. Advanced Drug Delivery Reviews 2010; 62:1337-43.
2. Couser W.G. Pathogenesis of glomerular damage in glomerulonephritis. Nephrology Dialysis Transplantation 1998, 13(Suppl. 1):10-15.
3. Adler S.G., Johnson K., Louie J.S., Liebling M.R., Cohen A.H. Lupus membranous glomerulonephritis: different prognostic subgroups obscured by imprecise histologic classifications. Modern Pathology 1990, 3:186-191.
4. Arce-Salinas C.A., Villa A.R., Martinez-Rueda J.O., Munoz L., Cardiel M.H., Alcocer-Varela J., Alarcon-Segovia D. Factors associated with chronic renal failure in 121 patients with diffuse proliferative lupus nephritis: a case-control study. Lupus 1995, 4:197-203.
5. Bagavant H., Fu S.M. Pathogenesis of kidney disease in systemic lupus erythematosus. Current Opinion in Rheumatology 2009, 21:489-494.
6. Kulkarni O., Anders H.J. Chemokines in lupus nephritis. Frontiers in Bioscience 2008, 13:3312-3320.
7. Morimoto S., Tokano Y., Nakano S., Watanabe T., Tamayama Y., Mitsuo A., Suzuki J., Kaneko H., Sekigawa I., Takasaki Y. Chemoattractant mechanism of Th1 cells in class III and IV lupus nephritis. Autoimmunity 2009, 42:143-149.
8. Giunti S., Pinach S., Arnaldi L., Viberti G., Perin P.C., Camussi G., Gruden G. The MCP-1/CCR2 system has direct proinflammatory effects in human mesangial cells. Kidney International 2006, 69:856-863.
9. Sinico R.A., Bollini B., Sabadini E., Di Toma L., Radice A. The use of laboratory tests in diagnosis and monitoring of systemic lupus erythematosus. Journal of Nephrology 2002, 15(Suppl. 6):S20-S27.
10. Marks SD, Shah V, Pilkington C, Tullus K. Urinary monocyte chemoattractant protein-1 correlates with disease activity in lupus nephritis. Pediatric Nephrology 2010; 25:2283-8.
11. Li Y., Tucci M., Narain S., Barnes E.V., Sobel E.S., Segal M.S., Richards H.B. Urinary biomarkers in lupus nephritis. Autoimmunity Reviews 2006, 5:383-388.
12. Ka S.M., Cheng C.W., Shui H.A., Wu W.M., Chang D.M., Lin Y.C., Chen A. Mesangial cells of lupus-prone mice are sensitive to chemokine production. Arthritis Researchand Therapy 2007, 9:R67.
13. Fu Y., Xie C., Yan M., Li Q., Joh J.W., Lu C., Mohan C. The lipopolysaccharide-triggered mesangial transcriptome: evaluating the role of interferon regulatory factor-1. Kidney International 2005, 67:1350-1361.
14. Patole P.S., Pawar R.D., Lech M., Zecher D., Schmidt H., Segerer S., Ellwart A., Henger A., Kretzler M., Anders H.J. Expression and regulation of Toll-like receptors in lupus-like immune complex glomerulonephritis of MRL-Fas(lpr) mice. Nephrology Dialysis Transplantation 2006, 21:3062-3073.
15. Pawar R.D., Patole P.S., Wornle M., Anders H.J. Microbial nucleic acids pay a Toll in kidney disease. American Journal of Physiology: Renal Physiology 2006, 291:F509-F516.
16. Lichtnekert J., Vielhauer V., Zecher D., Kulkarni O.P., Clauss S., Segerer S., Hornung V., Mayadas T.N., Beutler B., Akira S., Anders H.J. Trif is not required for immune complex glomerulonephritis: dying cells activate mesangial cells via Tlr2/Myd88 rather than Tlr3/Trif. American Journal of Physiology: Renal Physiology 2009, 296:F867-F874.
17. Shen H., Panchanathan R., Rajavelu P., Duan X., Gould K.A., Choubey D. Gender-dependent expression of murine Irf5 gene: implications for sex bias in autoimmunity. Journal of Molecular Cell Biology 2010; 2:284-90.
18. Inui A., Ogasawara H., Naito T., Sekigawa I., Takasaki Y., Hayashida Y., Takamori K., Ogawa H. Estrogen receptor expression by peripheral blood mononuclear cells of patients with systemic lupus erythematosus. Clinical Rheumatology 2007, 26:1675-1678.
19. Bynote K.K., Hackenberg J.M., Korach K.S., Lubahn D.B., Lane P.H., Gould K.A. Estrogen receptor-alpha deficiency attenuates autoimmune disease in (NZB x NZW) F1 mice. Genes and Immunity 2008, 9:137-152.
20. Svenson J.L., EuDaly J., Ruiz P., Korach K.S., Gilkeson G.S. Impact of estrogen receptor deficiency on disease expression in the NZM2410 lupus prone mouse. Clinical Immunology 2008, 128:259-268.
21. Cunningham M.A., Naga O.S., Eudaly J.G., Scott J.L., Gilkeson G.S. Estrogen receptor alpha modulates Toll-like receptor signaling in murine lupus. Clinical Immunology 2012, 144:1-12.
22. Chin M., Isono M., Isshiki K., Araki S., Sugimoto T., Guo B., Sato H., Haneda M., Kashiwagi A., Koya D. Estrogen and raloxifene, a selective estrogen receptor modulator, ameliorate renal damage in db/db mice. American Journal of Pathology 2005, 166:1629-1636.
23. Kurogi Y. Mesangial cell proliferation inhibitors for the treatment of proliferative glomerular disease. Medicinal Research Reviews 2003, 23:15-31.
24. Neugarten J., Ghossein C., Silbiger S. Estradiol inhibits mesangial cell-mediated oxidation of low-density lipoprotein. Journal of Laboratory and Clinical Medicine 1995, 126:385-391.
25. Neugarten J., Acharya A., Lei J., Silbiger S. Selective estrogen receptor modulators suppress mesangial cell collagen synthesis. American Journal of Physiology: Renal Physiology 2000, 279:F309-F318.
26. Potier M., Elliot S.J., Tack I., Lenz O., Striker G.E., Striker L.J., Karl M. Expression and regulation of estrogen receptors in mesangial cells: influence on matrix metalloproteinase-9. Journal of the American Society of Nephrology: JASN 2001, 12:241-251.
27. Tiwari-Woodruff S., Voskuhl R.R. Neuroprotective and anti-inflammatory effects of estrogen receptor ligand treatment in mice. Journal of the Neurological Sciences 2009, 286:81-85.
28. Offner H., Polanczyk M. A potential role for estrogen in experimental autoimmune encephalomyelitis and multiple sclerosis. Annals of the New York Academy of Sciences 2006, 1089:343-372.
29. Mene P. Mesangial cell cultures. Journal of Nephrology 2001, 14:198-203.
30. Thomas R.S., Sarwar N., Phoenix F., Coombes R.C., Ali S. Phosphorylation at serines 104 and 106 by Erk1/2 MAPK is important for estrogen receptor-alpha activity. Journal of Molecular Endocrinology 2008, 40:173-184.
31. Cheng J., Zhang C., Shapiro D.J. A functional serine 118 phosphorylation site in estrogen receptor-alpha is required for down-regulation of gene expression by 17beta-estradiol and 4-hydroxytamoxifen. Endocrinology 2007, 148:4634-4641.
32. Nowling T.K., Gilkeson G.S. Mechanisms of tissue injury in lupus nephritis. Arthritis Research and Therapy 2011, 13:250.
33. Feng W., Webb P., Nguyen P., Liu X., Li J., Karin M., Kushner P.J. Potentiation of estrogen receptor activation function 1 (AF-1) by Src/JNK through a serine 118-independent pathway. Molecular Endocrinology 2001, 15:32-45.
34. Colasanti T., Maselli A., Conti F., Sanchez M., Alessandri C., Barbati C., Vacirca D., Tinari A., Chiarotti F., Giovannetti A., Franconi F., Valesini G., Malorni W., Pierdominici M., Ortona E. Autoantibodies to estrogen receptor alpha interfere with T lymphocyte homeostasis and are associated with disease activity in systemic lupus erythematosus. Arthritis and Rheumatism 2012, 64:778-787.
35. Blush J., Lei J., Ju W., Silbiger S., Pullman J., Neugarten J. Estradiol reverses renal injury in Alb/TGF-beta1 transgenic mice. Kidney International 2004, 66:2148-2154.
36. Negulescu O., Bognar I., Lei J., Devarajan P., Silbiger S., Neugarten J. Estradiol reverses TGF-beta1-induced mesangial cell apoptosis by a casein kinase 2-dependent mechanism. Kidney International 2002, 62:1989-1998.
37. Potier M., Karl M., Zheng F., Elliot S.J., Striker G.E., Striker L.J. Estrogen-related abnormalities in glomerulosclerosis-prone mice: reduced mesangial cell estrogen receptor expression and prosclerotic response to estrogens. American Journal of Pathology 2002, 160:1877-1885.
38. Simoncini T., Scorticati C., Mannella P., Fadiel A., Giretti M.S., Fu X.D., Baldacci C., Garibaldi S., Caruso A., Fornari L., Naftolin F., Genazzani A.R. Estrogen receptor alpha interacts with Galpha13 to drive actin remodeling and endothelial cell migration via the RhoA/Rho kinase/moesin pathway. Molecular Endocrinology 2006, 20:1756-1771.
39. Somjen D., Kohen F., Gayer B., Sharon O., Baz M., Limor R., Kulik T., Knoll E., Stern N. Role of putative membrane receptors in the effects of estradiol on human vascular cell growth. American Journal of Hypertension 2004, 17:462-469.
40. Harrington W.R., Sheng S., Barnett D.H., Petz L.N., Katzenellenbogen J.A., Katzenellenbogen B.S. Activities of estrogen receptor alpha- and beta-selective ligands at diverse estrogen responsive gene sites mediating transactivation or transrepression. Molecular and Cellular Endocrinology 2003, 206:13-22.
41. Feng F., Nyland J., Banyai M., Tatum A., Silverstone A.E., Gavalchin J. The induction of the lupus phenotype by estrogen is via an estrogen receptor-alpha-dependent pathway. Clinical Immunology 2010; 134:226-36.
42. Hill L., Jeganathan V., Chinnasamy P., Grimaldi C., Diamond B. Differential roles of estrogen receptors alpha and beta in control of B-cell maturation and selection. Molecular Medicine 2011, 17:211-220.
43. Dai R., Phillips R.A., Karpuzoglu E., Khan D., Ahmed S.A. Estrogen regulates transcription factors STAT-1 and NF-kappaB to promote inducible nitric oxide synthase and inflammatory responses. Journal of Immunology 2009, 183:6998-7005.
44. Tetsuka T., Srivastava S.K., Morrison A.R. Tyrosine kinase inhibitors, genistein and herbimycin A, do not block interleukin-1 beta-induced activation of NF-kappa B in rat mesangial cells. Biochemical and Biophysical Research Communications 1996, 218:808-812.
45. Lupien M., Eeckhoute J., Meyer C.A., Krum S.A., Rhodes D.R., Liu X.S., Brown M. Coactivator function defines the active estrogen receptor alpha cistrome. Molecular and Cellular Biology 2009, 29:3413-3423.
46. Kininis M., Chen B.S., Diehl A.G., Isaacs G.D., Zhang T., Siepel A.C., Clark A.G., Kraus W.L. Genomic analyses of transcription factor binding, histone acetylation, and gene expression reveal mechanistically distinct classes of estrogen-regulated promoters. Molecular and Cellular Biology 2007, 27:5090-5104.
47. Gingerich S., Kim G.L., Chalmers J.A., Koletar M.M., Wang X., Wang Y., Belsham D.D. Estrogen receptor alpha and G-protein coupled receptor 30 mediate the neuroprotective effects of 17beta-estradiol in novel murine hippocampal cell models. Neuroscience 2010; 170:54-66.
48. Ambrosino C., Tarallo R., Bamundo A., Cuomo D., Franci G., Nassa G., Paris O., Ravo M., Giovane A., Zambrano N., Lepikhova T., Janne O.A., Baumann M., Nyman T.A., Cicatiello L., Weisz A. Identification of a hormone-regulated dynamic nuclear actin network associated with estrogen receptor alpha in human breast cancer cell nuclei. Molecular and Cellular Proteomics 2010; 9:1352-67.
49. Burns K.A., Li Y., Arao Y., Petrovich R.M., Korach K.S. Selective mutations in estrogen receptor alpha D-domain alters nuclear translocation and non-estrogen response element gene regulatory mechanisms. Journal of Biological Chemistry 2011; 286:12640-9.
50. Anders H.J., Banas B., Schlondorff D. Signaling danger: toll-like receptors and their potential roles in kidney disease. Journal of the American Society of Nephrology: JASN 2004, 15:854-867.